Cargando…
Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarker
BACKGROUND: Identifying blood-based DNA methylation patterns is a minimally invasive way to detect biomarkers in predicting age, characteristics of certain diseases and conditions, as well as responses to immunotherapies. As microarray platforms continue to evolve and increase the scope of CpGs meas...
Autores principales: | Tang, Emily, Wiencke, John K., Warrier, Gayathri, Hansen, Helen, McCoy, Lucie, Rice, Terri, Bracci, Paige M., Wrensch, Margaret, Taylor, Jennie W., Clarke, Jennifer L., Koestler, Devin C., Salas, Lucas A., Christensen, Brock C., Kelsey, Karl T., Molinaro, Annette M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617416/ https://www.ncbi.nlm.nih.gov/pubmed/36307860 http://dx.doi.org/10.1186/s13148-022-01352-1 |
Ejemplares similares
-
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival
por: Wiencke, J. K., et al.
Publicado: (2022) -
Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival
por: Wiencke, John K., et al.
Publicado: (2017) -
Pre-surgery immune profiles of adult glioma patients
por: Bracci, Paige M., et al.
Publicado: (2022) -
Comparative analysis of the DNA methylation landscape in CD4, CD8, and B memory lineages
por: Zhang, Ze, et al.
Publicado: (2022) -
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival
por: Kachuri, Linda, et al.
Publicado: (2023)